Journal
TALANTA
Volume 171, Issue -, Pages 229-235Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.talanta.2017.05.007
Keywords
Enzyme-free immunoassay; 1,1 '-oxalyldiimidazole chemiluminescence; Microsphere; Fluorescence; Thyroid stimulating hormone (TSH); Thyroid cancer
Categories
Funding
- Luminescent MD, LLC. [LST-2014-5]
Ask authors/readers for more resources
Based on the chemiluminescent resonance energy transfer (CRET) from high-energy intermediate formed in 1,11-oxalyldiimidazole chemiluminescence (ODI-CL) reaction to fluorescent microsphere-conjugated detection antibody, a cost-effective and highly sensitive enzyme-free sandwich immunoassay with chemiluminescence detection was developed for the early diagnosis of thyroid cancer. Thyroid stimulating hormone (TSH) primary antibody immobilized on paramagnetic bead captures rapidly TSH in human serum within 15 min. Also, TSH detection antibody-conjugated yellow-green microsphere, capable of emitting green light, rapidly interacted with TSH-bound TSH primary antibody immobilized on paramagnetic bead during the 30-min incubation at room temperature. The sandwich complexes immobilized on paramagnetic in PBS buffer (pH 7.4) emit bright green light with the addition of ODI-CL reagents (e.g., H2O2, ODI). The dynamic range of enzyme-free sandwich immunoassay was 0.037-180 mu IU ml(-1) with 3-5% coefficient of variation. The limit of detection (LOD=background+3 sigma) of the enzyme free sandwich immunoassay was as low as 0.011 mu IU ml(-1). We expect that the enzyme free sandwich immunoassay with ODI-CL detection can be a new assay method for the early diagnosis of thyroid cancer with statistically acceptable accuracy, precision, and reproducibility.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available